Literature DB >> 9160664

Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment.

T D Randall1, I L Weissman.   

Abstract

A significant fraction of hematopoietic stem cells (HSCs) have been shown to be resistant to the effects of cytotoxic agents such as 5-fluorouracil (5-FU), which is thought to eliminate many of the rapidly dividing, more committed progenitors in the bone marrow and to provide a relatively enriched population of the most primitive hematopoietic progenitor cells. Although differences between 5-FU-enriched progenitor populations and those from normal bone marrow have been described, it remained unclear if these differences reflected characteristics of the most primitive stem cells that were revealed by 5-FU, or if there were changes in the stem-cell population itself. Here, we have examined some of the properties of the stem cells in the bone marrow before and after 5-FU treatment and have defined several activation-related changes in the stem-cell population. We found that long-term reconstituting stem cells decrease their expression of the growth factor receptor c-kit by 10-fold and increase their expression of the integrin Mac-1 (CD11b). These changes begin as early as 24 hours after 5-FU treatment and are most pronounced within 2 to 3 days. This activated phenotype of HSCs isolated from 5-FU-treated mice is similar to the phenotype of stem cells found in the fetal liver and to the phenotype of transiently repopulating progenitors in normal bone marrow. We found that cell cycle is induced concomitantly with these physical changes, and within 2 days as many as 29% of the stem-cell population is in the S/G2/M phases of the cell cycle. Furthermore, when examined at a clonal level, we found that 5-FU did not appear to eliminate many of the transient, multipotent progenitors from the bone marrow that were found to be copurified with long-term repopulating, activated stem cells. These results demonstrate the sensitivity of the hematopoietic system to changes in its homeostasis and correlate the expression of several important surface molecules with the activation state of HSCs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160664

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  98 in total

1.  In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells.

Authors:  S H Cheshier; S J Morrison; X Liao; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 2.  Stem cell heterogeneity: implications for aging and regenerative medicine.

Authors:  Christa E Muller-Sieburg; Hans B Sieburg; Jeff M Bernitz; Giulio Cattarossi
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

3.  Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation.

Authors:  Michael J Nemeth; Martha R Kirby; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element.

Authors:  Hartmut Geiger; Gabriela Rennebeck; Gary Van Zant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

5.  A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity.

Authors:  Darrell N Kotton; Attila J Fabian; Richard C Mulligan
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

6.  The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress.

Authors:  Deidre Daria; Marie-Dominique Filippi; Erik S Knudsen; Roberta Faccio; Zhixiong Li; Theodosia Kalfa; Hartmut Geiger
Journal:  Blood       Date:  2007-11-29       Impact factor: 22.113

7.  Combinatorial Gata2 and Sca1 expression defines hematopoietic stem cells in the bone marrow niche.

Authors:  Norio Suzuki; Osamu Ohneda; Naoko Minegishi; Mitsuo Nishikawa; Takayuki Ohta; Satoru Takahashi; James Douglas Engel; Masayuki Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

8.  Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging.

Authors:  Lisa M Guerrettaz; Sara A Johnson; John C Cambier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

9.  Epidermal Growth Factor and Granulocyte Colony Stimulating Factor Signaling Are Synergistic for Hematopoietic Regeneration.

Authors:  Sadhna O Piryani; Angel Y F Kam; Evelyna G Kliassov; Benny J Chen; Neil L Spector; John P Chute; David S Hsu; Nelson J Chao; Phuong L Doan
Journal:  Stem Cells       Date:  2017-11-10       Impact factor: 6.277

10.  Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells.

Authors:  Kameshwar P Singh; Amber Wyman; Fanny L Casado; Russell W Garrett; Thomas A Gasiewicz
Journal:  Carcinogenesis       Date:  2008-09-26       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.